Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19. Chandra, A., Gurjar, V., Qamar, I., & Singh, N. Journal of Biomolecular Structure and Dynamics, 39(12):4201-4211, Taylor and Francis Ltd., 2021. Paper doi bibtex @ARTICLE{Chandra20214201,
author={Chandra, A. and Gurjar, V. and Qamar, I. and Singh, N.},
title={Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19},
journal={Journal of Biomolecular Structure and Dynamics},
year={2021},
volume={39},
number={12},
pages={4201-4211},
doi={10.1080/07391102.2020.1775127},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087029269&doi=10.1080%2f07391102.2020.1775127&partnerID=40&md5=02e43eec39db30c92a005b2b9da646ab},
publisher={Taylor and Francis Ltd.},
issn={07391102},
coden={JBSDD},
abbrev_source_title={J. Biomol. Struct. Dyn.},
}
Downloads: 0
{"_id":"FbngD6dgHtM3Gbcnu","bibbaseid":"chandra-gurjar-qamar-singh-identificationofpotentialinhibitorsofsarscov2endoribonucleaseendoufromfdaapproveddrugsadrugrepurposingapproachtofindtherapeuticsforcovid19-2021","author_short":["Chandra, A.","Gurjar, V.","Qamar, I.","Singh, N."],"bibdata":{"bibtype":"article","type":"article","author":[{"propositions":[],"lastnames":["Chandra"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Gurjar"],"firstnames":["V."],"suffixes":[]},{"propositions":[],"lastnames":["Qamar"],"firstnames":["I."],"suffixes":[]},{"propositions":[],"lastnames":["Singh"],"firstnames":["N."],"suffixes":[]}],"title":"Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19","journal":"Journal of Biomolecular Structure and Dynamics","year":"2021","volume":"39","number":"12","pages":"4201-4211","doi":"10.1080/07391102.2020.1775127","url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087029269&doi=10.1080%2f07391102.2020.1775127&partnerID=40&md5=02e43eec39db30c92a005b2b9da646ab","publisher":"Taylor and Francis Ltd.","issn":"07391102","coden":"JBSDD","abbrev_source_title":"J. Biomol. Struct. Dyn.","bibtex":"@ARTICLE{Chandra20214201,\nauthor={Chandra, A. and Gurjar, V. and Qamar, I. and Singh, N.},\ntitle={Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19},\njournal={Journal of Biomolecular Structure and Dynamics},\nyear={2021},\nvolume={39},\nnumber={12},\npages={4201-4211},\ndoi={10.1080/07391102.2020.1775127},\nurl={https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087029269&doi=10.1080%2f07391102.2020.1775127&partnerID=40&md5=02e43eec39db30c92a005b2b9da646ab},\npublisher={Taylor and Francis Ltd.},\nissn={07391102},\ncoden={JBSDD},\nabbrev_source_title={J. Biomol. Struct. Dyn.},\n}\n\n","author_short":["Chandra, A.","Gurjar, V.","Qamar, I.","Singh, N."],"bibbaseid":"chandra-gurjar-qamar-singh-identificationofpotentialinhibitorsofsarscov2endoribonucleaseendoufromfdaapproveddrugsadrugrepurposingapproachtofindtherapeuticsforcovid19-2021","role":"author","urls":{"Paper":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087029269&doi=10.1080%2f07391102.2020.1775127&partnerID=40&md5=02e43eec39db30c92a005b2b9da646ab"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/NxEM4iawMpjoHHRBZ/scopus (1).bib","dataSources":["kR49ddyQuYfpQEpzM"],"keywords":[],"search_terms":["identification","potential","inhibitors","sars","cov","endoribonuclease","endou","fda","approved","drugs","drug","repurposing","approach","find","therapeutics","covid","chandra","gurjar","qamar","singh"],"title":"Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19","year":2021}